Turmeric As Effective As 14 Drugs
Lipitor/Atorvastatin(cholesterol medication): A 2008 study
published in the journal Drugs in R & D found that a standardized
preparation of curcuminoids from Turmeric compared favorably to the drug
atorvastatin (Lipitor) on endothelial dysfunction, the underlying
pathology of the blood vessels that drives atherosclerosis, in association with reductions in inflammation and oxidative stress in type 2 diabetic patients.
Corticosteroids (steroid medications): A 1999 study published in the journal Phytotherapy Research found that the primary polyphenol in turmeric, the saffron colored pigment known as curcumin, compared favorably to steroids in the management of chronic anterior uveitis, an inflammatory eye disease. A 2008 study published in Critical Care Medicine found that curcumin compared favorably to the corticosteroid drug dexamethasone in the animal model as an alternative therapy for protecting lung transplantation-associated injury by down-regulating inflammatory genes. An earlier 2003 study published in Cancer Letters found the same drug also compared favorably to dexamethasone in a lung ischaemia-repurfusion injury model. [for additional
Prozac/Fluoxetine & Imipramine (antidepressants): A 2011 study published in the journal Acta Poloniae Pharmaceutica found that curcumin compared favorably to both drugs in reducing depressive behavior in an animal model.
Aspirin (blood thinner): A 1986 in vitro and ex vivo study published in the journal Arzneimittelforschung found that curcumin has anti-platelet and prostacyclin modulating effects compared to aspirin, indicating it may have value in patients prone to vascular thrombosis and requiring anti-arthritis therapy
Anti-inflammatory Drugs: A 2004 study published in the journal Oncogene found that curcumin (as well as resveratrol) were effective alternatives to the drugs aspirin, ibuprofen, sulindac, phenylbutazone, naproxen, indomethacin, diclofenac, dexamethasone, celecoxib, and tamoxifen in exerting anti-inflammatory and anti-proliferative activity against tumor cells
Oxaliplatin (chemotherapy drug): A 2007 study published in
the International Journal of Cancer found that curcumin compares
favorably with oxaliplatin as an antiproliferative agenet in colorectal cell
lines. [for additional curcumin and
colorectal cancer research – 52 abstracts]
Metformin (diabetes drug): A 2009 study published in the
journal Biochemitry and Biophysical Research Community explored how
curcumin might be valuable in treating diabetes, finding that it activates AMPK
(which increases glucose uptake) and suppresses gluconeogenic gene expression
(which suppresses glucose production in the liver) in hepatoma cells.
Interestingly, they found curcumin to be 500 times to 100,000 times (in the form
known as tetrahydrocurcuminoids(THC)) more potent than metformin in activating
AMPK and its downstream target acetyl-CoA carboxylase (ACC).
-Curcumin clears >80% HPV-
Click here to read the complete article.
Ulcerative Colitis and Crohn's disease- Effect of Turmeric is researched for these diseases and it seems help.Link to article.
READ MORE AT HERE.
Turmeric is one the most thoroughly researched plants in existence today. Its
medicinal properties and components (primarily curcumin) have been the subject of over
5600 peer-reviewed and published biomedical studies.
Corticosteroids (steroid medications): A 1999 study published in the journal Phytotherapy Research found that the primary polyphenol in turmeric, the saffron colored pigment known as curcumin, compared favorably to steroids in the management of chronic anterior uveitis, an inflammatory eye disease. A 2008 study published in Critical Care Medicine found that curcumin compared favorably to the corticosteroid drug dexamethasone in the animal model as an alternative therapy for protecting lung transplantation-associated injury by down-regulating inflammatory genes. An earlier 2003 study published in Cancer Letters found the same drug also compared favorably to dexamethasone in a lung ischaemia-repurfusion injury model. [for additional
Prozac/Fluoxetine & Imipramine (antidepressants): A 2011 study published in the journal Acta Poloniae Pharmaceutica found that curcumin compared favorably to both drugs in reducing depressive behavior in an animal model.
Aspirin (blood thinner): A 1986 in vitro and ex vivo study published in the journal Arzneimittelforschung found that curcumin has anti-platelet and prostacyclin modulating effects compared to aspirin, indicating it may have value in patients prone to vascular thrombosis and requiring anti-arthritis therapy
Anti-inflammatory Drugs: A 2004 study published in the journal Oncogene found that curcumin (as well as resveratrol) were effective alternatives to the drugs aspirin, ibuprofen, sulindac, phenylbutazone, naproxen, indomethacin, diclofenac, dexamethasone, celecoxib, and tamoxifen in exerting anti-inflammatory and anti-proliferative activity against tumor cells
Asian Pac J Cancer Prev. 2013 ;14(10):5753-9. PMID: 24289574
Curcumin and curcumin containing polyherbal preparations have demonstrated
anti-microbial and anti- viral properties in pre-clinical studies. Till date no
therapeutic intervention has been proved to be effective and safe in clearing
established cervical human papillomavirus (HPV) infection. The present study
evaluated the efficacy of Basant polyherbal vaginal cream (containing extracts
of curcumin, reetha, amla and aloe vera) and of curcumin vaginal capsules to
eliminate HPV infection from cervix. Women were screened by Pap smear and HPV
DNA test by PCR. HPV positive women without high grade cervical neoplasias
(N=287) were randomized to four intervention arms to be treated with vaginal
Basant cream, vaginal placebo cream, curcumin vaginal capsules and placebo
vaginal capsules respectively. All subjects were instructed to use one
application of the assigned formulation daily for 30 consecutive days except
during menstruation and recalled within seven days of the last application for
repeat HPV test, cytology and colposcopy. HPV clearance rate in Basant arm
(87.7%) was significantly higher than the combined placebo arms (73.3%).
Curcumin caused higher rate of clearance (81.3%) than placebo though the
difference was not statistically significant. Vaginal irritation and itching,
mostly mild to moderate, was significantly higher after Basant application. No
serious adverse events were noted.
Article
Published Date : Dec 31, 2012
No comments:
Post a Comment